The NRG-CC005/FORTE colorectal cancer prevention clinical trial is open for enrollment! @nrgonc @NCIprevention #GITwitter#MedTwitter FORTE clinical trial
FORTE is quickly racing toward 50% enrollment, accruing over 4000 participants by the beginning of February 2026. As the study team continues to welcome new sites, explore activating and increasing accrual to NRG-CC005. Activation materials can be found on CTSU, under NRG-CC005.
Thanks to the efforts of the national clinical research teams supporting enrollment to NRG-CC005, the FORTE team is excited to report that the trial set a new record of 170 participants in April 2026.
Congratulations to the @FORTEStudy on setting a record for accruals during April & racing toward 50% enrollment by summer! Read about that & more in the May issue of FORTE Fridays ➡️https://t.co/0a2ZHJggqA
In our April newsletter issue, the @FORTEStudy section highlights an upcoming Coordinator Session that will coincide with the #NRG2026 Summer Meeting. Read more ➡️https://t.co/rdwEYBA6lH
March is colorectal cancer awareness month! FORTE is a colorectal cancer prevention #clinicaltrial looking to answer when patients who had 1-2 small benign polyps removed should have repeat surveillance colonoscopies. Learn more: https://t.co/B6ncYsVhXk @NRGonc@fortestudy
For #ColorectalCancer month, we are focusing on the @FORTEStudy! Read the study update for March 2026 including upcoming dates to remember, accrual updates and milestones, and more! Read here: https://t.co/8YZLOiTivl
Currently enrolling participants, @FORTEStudy is a #colorectalcancer prevention trial looking to answer when patients who had 1-2 small benign polyps removed during a colonoscopy, have a repeat surveillance colonoscopy? Learn more about FORTE: https://t.co/zqsdhHd9fn
February is #NationalCancerPreventionMonth. One in 3 Americans will develop cancer in their lifetime. NRG has 2 prevention #clinicaltrials currently enrolling participants: @FORTEstudy & SOROCk. Learn more about both in our Feb newsletter: https://t.co/cAFxjfZEX9
NRG's February newsletter Cancer Prevention Month feature: The FORTE Study! The trial has now accrued 4,000 participants - nearing the 50% enrollment mark! Learn more about top accruers and site resources in this month's update: https://t.co/G8YnGeLEg3 @fortestudy
Another milestone
Achieved in record time, just over 7 months needed to recruit 1,000 additional patients
So greatful to all of the participants and hundreds of people working hard to accomplish this ambitious trial
The February issue of FORTE Fridays is now available! @FORTEStudy is quickly racing toward 50% enrollment, accruing over 4000 participants. Thank you for the ongoing support of this important trial! https://t.co/Krwtck66Tu
As Digestive Disease Week approaches, DDW introduced DDW Legends, a new series celebrating the ideas, mentorship, and leadership that have helped define DDW over the years.
We're excited to see FORTE Protocol Chair, @rockscho, featured : https://t.co/x8UKAm4J8Y
The @FORTEStudy recently met the accrual milestone of 3800 participants. Check out all of the FORTE updates for December here ➡️ https://t.co/OWjMPj7FMp
Catch up with the January updates for the @FORTEStudy including how the trial reached the 40% accrual milestone during the month of December! ➡️https://t.co/zRwY5cL4aG
Our December newsletter issue is out TODAY! Check out this edition for info on the upcoming #NRG2026 Winter Meeting, study news with 2 NEW video interviews with @Rrkotecha; PSC, Advocates & TSC columns, @FORTEStudy updates, NEW podcast episodes & more!https://t.co/EJVbGQvXfQ
It's FORTE Friday! Check out the latest issue: https://t.co/pbXqaG78nQ
FORTE is a #colorectalcancer prevention study looking to answer when should patients who had 1-2 small benign polyps removed during colonoscopy have repeat surveillance colonoscopy? @fortestudy